/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Robert M. Rifkin

Rocky Mountain Cancer Centers(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

257

Papers

4.7K

Citations

34

h-index

81

i10-index

Robert M. Rifkin is an academic researcher from Rocky Mountain Cancer Centers. The author has contributed to research in topics: Multiple Myeloma Research and Treatments & Protein Degradation and Inhibitors & Cancer Treatment and Pharmacology. The author has an h-index of 34, co-authored 219 publications.

ORCID: 0000-0003-3141-1518

Research Topics

Multiple Myeloma Research and Treatments Protein Degradation and Inhibitors Cancer Treatment and Pharmacology Peptidase Inhibition and Analysis Chronic Lymphocytic Leukemia Research

Papers by this author

works

Switching Reference Medicines to Biosimilars: A Systematic Literature Review of Clinical Outcomes

2018 · Drugs · 208 citations

https://doi.org/10.1007/s40265-018-0881-y

Hillel P. Cohen Andrew Blauvelt Robert M. Rifkin Silvio Danese

Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma

2014 · Blood Cancer Journal · 47 citations

https://doi.org/10.1038/bcj.2014.71

Sarit Assouline Elizabeth Chang Bruce D. Cheson Robert M. Rifkin

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

2018 · Annals of Hematology · 46 citations

https://doi.org/10.1007/s00277-018-3446-y

Rafat Abonour Lynne I. Wagner Brian G.M. Durie Sundar Jagannath

Effect of t (11;14) Abnormality on Outcomes of Patients With Newly Diagnosed Multiple Myeloma in the Connect MM Registry

2021 · Clinical Lymphoma Myeloma & Leukemia · 21 citations

https://doi.org/10.1016/j.clml.2021.08.007

Cristina Gasparetto Sundar Jagannath Robert M. Rifkin Brian G.M. Durie

Health-Related Quality of Life of Patients with Newly Diagnosed Multiple Myeloma Receiving Any or Lenalidomide Maintenance after Autologous Stem Cell Transplant in the Connect® MM Disease Registry

2016 · Blood · 13 citations

https://doi.org/10.1182/blood.v128.22.537.537

Rafat Abonour Brian G.M. Durie Sundar Jagannath Jatin J. Shah

Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findings From the Connect MM Disease Registry

2022 · Clinical Lymphoma Myeloma & Leukemia · 12 citations

https://doi.org/10.1016/j.clml.2022.11.008

Hans C. Lee Karthik Ramasamy Katja Weisel Rafat Abonour

Research topics

topics

Multiple Myeloma Research and Treatments

Protein Degradation and Inhibitors

Cancer Treatment and Pharmacology

Peptidase Inhibition and Analysis

Chronic Lymphocytic Leukemia Research

Chat about Author

Papers

Chat

Click to start Chat